 ##  [Innovation and digital](/node/538896 "Innovation and digital") 

  



 Novartis Manufacturing &amp; Supply recognized in the 2026 rankings for Gartner Global Supply Chain Top 25

  

We are proud that Novartis Manufacturing &amp; Supply has been recognized in the 2026 rankings for Gartner Global Supply Chain Top 25.

[Learn more](https://www.gartner.com/en/newsroom/press-releases/2026-06-17-gartner-announces-2026-rankings-of-the-global-supply-chain-top-25)



 

 

 



 



 Novartis Manufacturing &amp; Supply recognized in the 2025 Alcott Leaders in Supply Chain Award

  

We are proud that Novartis Manufacturing &amp; Supply has been recognized in the 2025 Alcott Leaders in Supply Chain Award.

[Learn more](https://gala.makersmovers.com/top-30-winners-of-2025/top-12-steffen-lang/)



 

 

 



 



 Novartis wins a Reuters Responsible Business Award for the Novartis in Society Integrated Report



  

The Novartis in Society Integrated Report 2021 wins in the Reporting and Transparency category, with judges saying it ”demonstrates how businesses can go beyond the current paradigm, setting an encouraging standard for future reporting practices for all businesses”.

[Learn more](https://events.reutersevents.com/sustainable-business/responsible-business-awards/winners)



 

 

 



 



 Novartis was included in Fortune’s World’s Most Admired Companies list



  

Novartis was once again included in the Fortune World's Most Admired Companies list, gaining a score of 7.5 (2021: 7.4) in the survey. This year, over 3 700 executives, directors and analysts completed the survey, with a total of 640 companies across 28 countries participating. Novartis ranked #5 in the pharmaceuticals industry list.

[Learn more](https://fortune.com/worlds-most-admired-companies/2022/)



 

 

 



 



 Recognized as a “Covid Champion” (Bronze) for 2021 by the Learning Performance Institute



  

Paying tribute to those who stood up to the mark in a time of trouble and made a real impact within the community in terms of supporting them through the pandemic.

[Learn more](https://www.thelpi.org/winners-of-the-learning-awards-2021-announced/)



 

 

 



 



 Novartis rises to #3 in the pharmaceutical category of the Fortune World’s Most Admired Companies list



  

Novartis rose to #3 in the Fortune World's Most Admired Companies Pharmaceuticals Industry list, from #4 in 2020 and 2019. Across the scored reputational dimensions, Novartis saw significant improvements in Social Responsibility (ranking as #4 most admired pharma company in this category in 2021 vs #8 in 2020) and Quality of Products (#4 in 2021 vs #7 in 2020). Novartis ranks #3 in Innovation and #2 In Global Competitiveness (the same as 2020).

[Learn more](https://fortune.com/worlds-most-admired-companies/)



 

 

 



 



 Novartis ranks second in 2021 Access to Medicine Index



  

Novartis maintained its position in the 2021 Access to Medicine Index, leading in its approach to product delivery, while performing strongly across all other areas of the Index.

[Learn more](https://accesstomedicinefoundation.org/access-to-medicine-index/2021-ranking)



 

 

 



 



 Novartis enters the Top 50 Most Innovative Companies list by Boston Consulting Group



  

Novartis is proud to be named one of the “Top 50 Most Innovative Companies in the World” by Boston Consulting Group. The list ranks companies based on a global survey of executives as well as the return they have produced for shareholders over the past three years.

[Learn more](https://www.bcg.com/de-de/publications/most-innovative-companies-historical-rankings)



 

 

 



 



 Novartis recognized with Learning Strategy Innovation Award 2019



  

We are delighted to be recognized for our efforts as we continue to go big on learning.

[Learn more](https://www.cornerstoneondemand.co.uk/company/newsroom/press-releases/cornerstone-names-winners-2019-emea-convergence-client-awards/)



 

 

 



 



 Fortune's Most Admired Pharmaceutical Companies 2020



  

Novartis has again been ranked #4 by Fortune Magazine as one of the most admired pharmaceutical companies in the world.

[Learn more](https://fortune.com/worlds-most-admired-companies/2020/novartis/)



 

 

 



 



 Novartis ranks #3 in 2018 Pharmaceutical Innovation Index



  

IdeaPharma’s PII ranks companies on their ability to bring products from early development to market and commercialize them successfully. Novartis moved up 9 spots, from #12 in 2017.

[Learn more](https://www.ideapharma.com/pii/)



 

 

 



 



 Fast Company’s 2018 World's Most Innovative Companies list



  

Novartis has been named #1 most innovative biotech company and ranked #21 overall by Fast Company. The ranking identifies the most notable innovations of the year.

[Learn more](https://www.fastcompany.com/company/novartis)



 

 

 



 



 Novartis on FORTUNE's list of the World's Most Admired Companies 2017



  

Novartis is proud to once again rank #2 in the FORTUNE World's Most Admired Companies Pharmaceuticals Industry list. This is the third consecutive year that Novartis ranked as the second-most-admired company in our sector, and the 13th consecutive year that Novartis is in the top three.

[Learn more](https://fortune.com/worlds-most-admired-companies/search/)



 

 

 



 



 MedAdNews Top 10 pipelines



  

Novartis is again honored to be included in the 2017 “Top 10 Pipelines” list published by MedAdNews.

[Learn more](https://www.medadnews-digital.com/medadnews/february_2017?pg=15#pg15)



 

 

 



 



 

 





 



- [Print](/node/538896/printable/print)
- [PDF](/node/538896/printable/pdf)